Evidence map›Paper›PMID 28275053›Full record

ArticleThe Journal of biological chemistry2017

Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness.

Joshua C Snyder, Lauren K Rochelle, Caroline Ray, Thomas F Pack, Cheryl B Bock, Veronica Lubkov, H Kim Lyerly, Alan S Waggoner, Larry S Barak, Marc G Caron

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Discovery of a functionally selective ghrelin receptor (GHSRProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. hThe Journal of experimental medicine · 2018
    Article
  15. Article
  16. The function of endocytosis in Wnt signaling.Cellular and molecular life sciences : CMLS · 2018
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Joshua C SnyderFrom the Departments of Cell Biology, joshua.snyder@duke.edu.
Lauren K RochelleFrom the Departments of Cell Biology.
Caroline RayFrom the Departments of Cell Biology.
Thomas F PackPharmacology and Cancer Biology and.
Cheryl B BockDuke Cancer Institute Transgenic Core, Duke University Medical Center, Durham, North Carolina 27712 and.
Veronica LubkovSurgery, and.
H Kim LyerlySurgery, and.
Alan S WaggonerDepartment of Biological Sciences and Molecular Biosensor and Imaging Center, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213.
Larry S BarakFrom the Departments of Cell Biology.
Marc G CaronFrom the Departments of Cell Biology, marc.caron@duke.edu.
Duke University Hospital · USDuke Medical Center · USDuke University · USImaging Center · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Clinical Oncology Research Career Development ProgramK12CA100639 · NCI · DUKE UNIVERSITY · PI LYERLY, HERBERT KIM · 2004 to 2013
$8.0M
Fluorescent Biosensors for Networks and PathwaysU54GM103529 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI WAGGONER, ALAN S. · 2012 to 2013
$6.3M
Science PlanP30DA029925 · NIDA · DUKE UNIVERSITY · PI CARON, MARC G. · 2010 to 2018
$6.2M
A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple OncogenesR33CA191198 · NCI · DUKE UNIVERSITY · PI CARON, MARC G. · 2015 to 2017
$1.2M
Supplemental Funds for K22 Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behaviorK22CA212058 · NCI · DUKE UNIVERSITY · PI SNYDER, JOSHUA CLAIR · 2017 to 2020
$622k
A Cancer Rainbow Mouse for the Simultaneous Assessment of Multiple OncogenesR21CA173245 · NCI · DUKE UNIVERSITY · PI CARON, MARC G. · 2012 to 2013
$476k
Dissecting the Distinct Arrestin Signaling Capabilities of the Short and Long Dopamine D2 Receptors as a Paradigm for Psychostimulant Addiction TreatmentF31DA041160 · NIDA · DUKE UNIVERSITY · PI PACK, THOMAS FRANKLIN · 2016 to 2017
$67k
NCI NIH HHS K12 CA100639NCI NIH HHS K22 CA212058NCI NIH HHS P30 CA014236NCI NIH HHS R21 CA173245NCI NIH HHS R33 CA191198NIDA NIH HHS F31 DA041160NIDA NIH HHS P30 DA029925NIGMS NIH HHS U54 GM103529
6 · The paper itself

Abstract

The leucine-rich G protein-coupled receptor-5 (LGR5) is expressed in adult tissue stem cells of many epithelia, and its overexpression is negatively correlated with cancer prognosis. LGR5 potentiates WNT/β-catenin signaling through its unique constitutive internalization property that clears negative regulators of the WNT-receptor complex from the membrane. However, both the mechanism and physiological relevance of LGR5 internalization are unclear. Therefore, a natural product library was screened to discover LGR5 internalization inhibitors and gain mechanistic insight into LGR5 internalization. The plant lignan justicidin B blocked the constitutive internalization of LGR5. Justicidin B is structurally similar to more potent vacuolar-type H

Indexed as

EndocytosisAdenosine TriphosphatasesAnimalsCell LineageCell Line, TumorCell ProliferationClathrinDioxolanesEpitheliumFemaleHomeostasisHumansLeucineLignansMiceMice, Inbred C57BLAdenosine TriphosphatasesClathrinDioxolanesjusticidinsLeucineLGR5 protein, humanLignansProtein IsoformsReceptors, G-Protein-Coupledclathrindrug screeningG protein-coupled receptor (GPCR)intestinal epitheliumLGR5natural productreceptor internalizationstem cellstraffickingvacuolar ATPase

Identifiers

PMID28275053
PMCPMC5409487
OpenAlexW2593260618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.